Stock Analysis of Vyant Bio Inc (VYNT) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code VYNT
Close 0.194
Change 0.0140 / 7.78 %
Volume 19116.00
Vol Change -228119.00 / 92.27 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthBullish
Growth Index Mild Growth
Value Index Good Value
Profitability Index Poor Profitability Stock
Stability Index Very Low Stability Stock


Fundamental View of Vyant Bio Inc
PE (TTM)

-0.0276

Very Poor
Price / Book

0.062

Excellent
Price / Sales

0.940

Very Good
Piotroski F Score

2.0

Poor
Market Cap

1227.78 K

Enterprise Value

-8191.22 K

ROA (TTM)

-141.35

Very Poor
ROE (TTM)

-224.90

Very Poor
Net Margin (TTM)

-3406.91

Very Poor
Revenue

41.99 %

666000
Net Profit

44.47 %

-22690.00 K
Debt to Equity

0.063

Excellent
Altman Z Score

-11.95

Very Poor
Quick Ratio

3.13

Very Good
Cash Ratio

2.74

Good


Highs/Lows of Vyant Bio Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.1725 12.46 % 1.54 % 0.20.16729-Dec-2326-Dec-23
Two Week0.165 17.58 % 3.42 % 0.20.1629-Dec-2319-Dec-23
One Month0.1775 9.30 % 5.60 % 0.20.159129-Dec-2311-Dec-23
Three Month0.17 14.12 % 5.95 % 0.210.1502-Nov-2309-Oct-23
Six Months0.2 3.00 % 17.48 % 0.290.14103-Aug-2325-Sep-23
One year0.7 72.29 % 27.52 % 1.580.14105-Jan-2325-Sep-23
Two year6.6 97.06 % 29.70 % 4.9410.14128-Jun-2225-Sep-23
Five year40.725 99.52 % 85.46 % 4.10.14118-Aug-2220-Sep-23
Ten year2086.5 99.99 % 182.41 % 3142.50.14120-Feb-1420-Sep-23


Technical View of Vyant Bio Inc
RSI

69.30

Neutral
MACD

0.0012

Strong Bullish
ADX

50.24

Strong Bullish
Super Trend

0.161

Mild Bullish
Williams %R

-14.67

Mild Bullish
CCI

192.69

Mild Bearish


EMA 5

0.180

Strong Bullish
EMA 15

0.174

Mild Bullish
EMA 50

0.175

Strong Bullish
EMA 100

0.206

Mild Bearish
SMA 100

0.173

Strong Bullish
SMA 200

0.259

Mild Bearish
SMA 5 / 20

0.177 / 0.172

Strong Bullish
SMA 15 / 50

0.170 / 0.175

Mild Bearish
SMA 50 / 200

0.175 / 0.259

Mild Bearish




Charts of Vyant Bio Inc


Returns of Vyant Bio Inc with Peers
Period / StockVYNTRVLPATNXAXLA
1 Week12.46%-58.16%-26.14%-19.82%
1 Mth9.30%-85.31%-26.14%-59.87%
3 Mth14.12%-97.11%-87.80%-96.16%
6mth-3.00%-98.60%-96.01%67.81%
1 Year-72.29%-99.36%-98.46%21.48%
2 Year-97.06%-99.35%-99.84%-80.82%
5 Years-99.52%-99.86%-99.96%-
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Vyant Bio Inc with Peers
Ratio / StockVYNTRVLPATNXAXLA
PE-0.0276-0.0129-0.0004-167.25
P/B0.0620.02400.0070-28346.08
ROA-141.35-72.04-44.63-434.24
ROE-224.90-185.93-433.13-10089.97
Debt To Equity0.0631.12-6.040.382
Revenue666000
41.99 % 		49721.00 K
184.10 % 		102821 K
14.44 % 		0
%
Net Income-22690.00 K
44.47 % 		-51692.00 K
20.38 % 		-103427.00 K
48.23 % 		-81186.00 K
25.62 %


Technicals of Vyant Bio Inc with Peers
Technical / StockVYNTRVLPATNXAXLA-
ADX50.2423.6815.5343.88
CMF-0.192-0.375-0.091-0.215
MFI60.0055.279.165.14
RSI69.3031.4030.1419.78
MACD Abv SignalTrueFalseFalseTrue
Price Above 50 MATrueFalseFalseFalse-
Price Above 200 MAFalseFalseFalseFalse-


About : Vyant Bio Inc

Address : 2 Executive Campus, Cherry Hill, NJ, United States, 08002
Tel : 201 479 1357
URL : https://www.vyantbio.com
Code : VYNT, ISIN : US92942V1098, Exchange : PINK, Country : USA
Fiscal Year End : December
IPO date : 05_Apr_2013
Employee Count : 4

Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). The company is based in Cherry Hill, New Jersey.


Note : All Data Generated at the End of Trading Hours (EOD Data)